Table 4 The different profiles of drug susceptibility among the different genotype family and different treated cases (n = 268).

From: The study on the association between Beijing genotype family and drug susceptibility phenotypes of Mycobacterium tuberculosis in Beijing

Characteristic

Category

Number of reported cases (%)

different genotype family

new and retreated cases

Beijing family (%)

Non-Beijing Family (%)

OR (95% CI)

p Value

New cases (%)

Retreated cases (%)

OR (95% CI)

p Value

All

 

268

219

49

  

207

61

  

DST profile

Pansusceptible

172(64.2)

138(63)

34(69.4)

  

154(74.4)

18(29.5)

2.52(1.69–3.75)

<0.001

INH

66(24.6)

57(26)

9(18.4)

1.47(0.75–2.66)

0.13

30(14.5)

36(59)

0.24(0.16–0.36)

<0.001

RIF

51(19)

42(19.2)

9(18.4)

1.04(0.54–2.00)

0.448

23(11.1)

28(45.9)

0.24(0.15–0.39)

<0.001

SM

64(23.9)

54(24.7)

10(20.4)

1.21(0.66–2.20)

0.264

37(17.9)

27(44.3)

0.40(0.27–0.606)

<0.001

EMB

18(6.7)

15(6.8)

3(6.1)

1.12(0.33–3.72)

0.427

4(1.9)

14(23)

0.08(0.03–0.25)

<0.001

MDR

44(16.4)

37(16.9)

7(14.3)

1.18(0.56–2.49)

0.328

18(8.7)

26(42.6)

0.20(0.12-0.35)

<0.001

  1. INH: Isoniazid; RIF: Rifampicin; SM: Streptomycin; EMB: Ethambutol; MDR: multi-drug resistance. p value indicates whether there is a significant difference between Beijing family and non-Beijing family (p < 0.05 represents a statistically significant difference).
Back to article page